Funding news
RevEng.AI logo

RevEng.AI Closes $15

Recently funded · $15.0M Series aTechnology, Information and MediaGBView source

Get the full RevEng.AI company profile

Access contacts, investors, buying signals & more

Open in Dashboard

A consortium of investors including the NATO Innovation Fund (NIF), Sands Capital, and In-Q-Tel has backed RevEng.AI, a company focused on securing software supply chains, with a $15.0M Series A investment. The funding round also saw participation from IQ Capital and Episode 1 Ventures.

RevEng.AI develops foundational deep learning AI models that understand binary machine code, using this expertise to rigorously validate software integrity at a binary level and enhance security in digital ecosystems.

RevEng.AI has raised $15 million in a Series A funding round led byNATO Innovation Fund (NIF), with participation from Sands Capital, In-Q-Tel,IQ Capital, and Episode 1 Ventures.

The funding will be used to support the growth and deployment of its binary-level software verification platform as demand increases from enterprise and defense organizations.𝗪𝗵𝗮𝘁 𝗶𝘁 𝗱𝗼𝗲𝘀Founded by James Patrick-Evans, RevEng.AI has developed a binary-native verification layer that analyses compiled software to detect hidden vulnerabilities and malicious functionality without needing acc

Unlock the full source

CEO quotes, investor details and growth metrics

Start free trial

Other United Kingdom companies recently funded

View all

Biggest recent AI rounds

Largest funding rounds in AI on Signalbase right now.

#CompanyAmount
1
Nuance Healthcare logo

Nuance Healthcare

United States

$19.7B
2
Anthropic logo

Anthropic

$13.0B
3
OpenAI logo

OpenAI

United States

$13.0B
4
Preferred Networks, Inc. logo

Preferred Networks, Inc.

Japan

¥10.0B
5
AIMAX logo

AIMAX

United Kingdom

$10.0B

Other recent Series a rounds

Companies that recently closed a Series a round.

#CompanyAmount
1
Waypoint Bio logo

Waypoint Bio

United States

$20.0M
2
Default logo

Default

United States

$20.0M
3
Abstract logo

Abstract

United States

$59.0M
4
Pacifico Biolabs logo

Pacifico Biolabs

Germany

€7.0M
5
Secretome Therapeutics logo

Secretome Therapeutics

United States

$30.0M